期刊文献+

一种灵敏的肌钙蛋白I方法对心肌梗死诊断的价值 被引量:5

Evaluation of a new generation cardiac troponin I assay in the diagnosis of acute myocardial infarction
下载PDF
导出
摘要 目的:评价新一代ACCESSAccuTnI化学发光测定试剂的检测性能和诊断急性心肌梗死(AMI)的敏感度和特异度。方法:在ACCESS全自动化学发光免疫分析仪上测定心肌肌钙蛋白I(cTnI)值,评价检测线性,乳糜、黄疸、溶血和抗凝剂对检测的干扰,试剂稳定性,功能灵敏度和10%的变异,健康人97.5%和99%分位值。测定AMI组和非AMI组的cTnI水平,应用受试者工作特征曲线(ROC曲线)分析cTnI对AMI的诊断敏感度和特异度。结果:检测线性0~50μg/L;黄疸、乳糜和溶血对测定结果没有显著影响,肝素抗凝血浆与血清测定结果差异无显著性(P<0.05);血浆样本定期保存于25℃可稳定24h,4℃稳定3d,-20℃时至少稳定1个月;cTnI呈偏态分布,第99百分位点值为0.047μg/L,相对应的日内变异系数(CV)为10%,日间CV为14%;ROC分析结果示cTnI浓度为0.1μg/L时诊断ST段抬高心肌梗死的敏感度、特异度分别为96%和84%,为最佳诊断临界值;而诊断非ST段抬高心肌梗死的最佳诊断临界值为0.06μg/L,敏感度、特异度为87.7%和80.2%。结论:本测定方法稳定,具有较好的抗干扰能力,对心肌梗死的诊断具有较高的灵敏度和特异度。 Objective To evaluate the analytical performance of a new generation cardiac troponin I assay and the sensitivity and specificity of cTnI in the diagnosis of acute myocardial infarction (AMI). Methods The 97.5 and 99 percentile upper reference limits (URLs), the sensitivity, the imprecision, the linearity, the stability and the interference response of the cTnI assay were evaluated at automated micropartical chemiluminescent immunoassay analyzer of ACCESS.The cTnI was examined in the AMI patients and the controls, and the data were then analyzed with receiver operating characteristic (ROC) curve statistical software. Results The assay was linear to 50 μg/L. Jaundice, chyle and hemolysis had no influence to the results. The assay had no significant difference between serum and heparin plasma(P〈0.05). The blood samples could stably stored at 25℃ for at least 24 hours, at 4℃ for 3 days or at -20℃ for at least 1 month. The 97.5 percentile URL was 0.02 μg/L (CV=19%), and the 99 percentile URL was 0.047 μg/l, (CV=14%). The ROC curve showed that the sensitivity and the specificity of the diagnostic cut-off point of cTnI both suqmssed 80%. The area under the curve was beyond 0.9. The optimal cut-off was 0.1 μg/L and 0.06 μg/L in the diagnosis of STEMI and NSTEMI. The sensitivity and the specificity were 96% and 84% respectively in the diagnosis of STEMI, and 87.7% and 80.2% respectively in the diagnosis of NSTEMI. Conclusions Beckman Coulter ACCESS AccuTnI assay is sensitive and stable with high sensitivity and specificity in the diagnosis of acute myocardial intarction.
出处 《诊断学理论与实践》 2006年第2期142-146,共5页 Journal of Diagnostics Concepts & Practice
关键词 心肌肌钙蛋白I 方法学评价 急性心肌梗死 ROC曲线 Cardiac tropinin I Methodology evaluation Acute myocardial infarction Receiver operatingcharacter curve
  • 相关文献

参考文献3

二级参考文献59

  • 1[1]Quillard M,Koning R,Andres H,et al.Determination of cardiac troponin I on Stratus analyzer:propective evalation in unstable anfina[J].Ann Biol Clin,1996,54:359.
  • 2[2]Shi QW ,Ling MF,ZHANG XC,et al.Degredation o fcardiac troponin I in serum complicates comparisons of cardiac troponin I assays[J].Clin Chem,1999,45(7):1018.
  • 3[3]Wu AHB,Feng YJ,Moore R,et al.Characterizatin of cardiac troponin subunit release into serum after acute myocardial infarction and comparison of assays for troponin T and I[J].Clin Chem,1998,44:1198.
  • 4[4]Lavinne A,Cauliez B,Eltchaniof H,et al.Analytical and clinical performance of the immulite cardiac troponin Iassay[J].Clin Chem,2000,46(12):1989.
  • 5[5]Per Venge, Lindahl B, Wallentin L. New generation cardiac troponin I assay for the access immunoassay system[J]. Clin Chem, 2001 ,47(5):959.
  • 6[10]Morrow DA, Rifai N, Antman EM, et al. C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in myocardial infarction [J]. J Am Coll Cardiol, 1998,31(7):1460-1465.
  • 7[11]Anzai T, Yoshikawa T, Shiraki H, et al. C-reactive protein as a predictor of infarct expansion and cardiac rupture after a first Q-wave acute myocardial infarction [J].Circulation, 1997,96(3):778-784.
  • 8[12]Mueller C, Buettner HJ, Hodgson JM, et al. Inflammation and long-term mortality after non-ST elevation acute coronary syndrome treated with a very early invasive strategy in 1042 consecutive patients [J]. Circulation,2002,105(12):1412-1415.
  • 9[13]James SK, Armstrong P, Barnathan E, et al. Troponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome: a GUSTO-IV substudy[J]. J Am Coll Cardiol, 2003,41(6):916-924.
  • 10[14]Morrow DA, Rifai N, Tanasijevic MJ, et al. Clinical efficacy of three assays for cardiac troponin I for risk stratification in acute coronary syndromes: A thrombolysis in myocardial infarction (TIMI) 11B substudy[J]. Clin Chem.2000,46(4):453-460.

共引文献31

同被引文献32

引证文献5

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部